Results 171 to 180 of about 384,078 (314)
This work summarizes the efficacy and mechanisms of probiotics in CRC treatment, providing a comprehensive overview of various encapsulation methods such as microcapsules, hydrogels, single‐cell nanocoatings, and nanofibers for targeted probiotic delivery to inflammatory sites, with particular emphasis on the potential advantages of emerging single ...
Hao Zhong+5 more
wiley +1 more source
This study uncovers that CD38high monocytes discriminate sepsis and sterile inflammation and are associated with 28‐day mortality in bacterial sepsis. Targeting CD38 therapy reduces inflammatory response in monocytes and in sepsis mice model. Mechanistically, CD38‐HIF‐1α/glycolysis/MGO loop exacerbates sepsis‐induced immune dysregulation.
Ning Hua+19 more
wiley +1 more source
Plasmin Cleavage of Beta-2-Glycoprotein I Alters its Structure and Ability to Bind to Pathogenic Antibodies [PDF]
Hannah F. Bradford+12 more
openalex +2 more sources
Adhesion mechanism of human beta 2-glycoprotein I to phospholipids based on its crystal structure
Barend Bouma
openalex +1 more source
Increased concentrations of interleukin-6 and interleukin-1 receptor antagonist and decreased concentrations of beta-2-glycoprotein I in Gambian children with cerebral malaria [PDF]
Palle Jakobsen+9 more
openalex +1 more source
This study develops lipid nanoparticles (LNPs) combining cationic and ionizable lipids for efficient cytosolic protein delivery. Optimized LNPs deliver functional proteins, including antibodies, enzymes, and Cas9, with high serum stability and albumin‐mediated endocytosis.
Lanfang Ren+6 more
wiley +1 more source
Lupus anticoagulant activity of some antiphospholipid antibodies against phospholipid bound beta 2 glycoprotein I. [PDF]
David Keeling+4 more
openalex +1 more source
This study identifies TREM2+ macrophages as key contributors to pathological bone formation in ankylosing spondylitis (AS). These macrophages mediate pathological new bone formation via the CREG1‐IGF2R‐PI3K‐AKT pathway and are regulated by IL‐33 through STAT6 phosphorylation.
Wenjun Hao+16 more
wiley +1 more source
Inhibitory and enhancing activity of beta 2-glycoprotein I on antiphospholipid autoantibody binding. [PDF]
H. M. Cheng
openalex +1 more source
Beta 2 glycoprotein I Valine247Leucine polymorphism in patients with antiphospholipid syndrome
Tekeoglu, Senem+5 more
openaire +3 more sources